Gottlieb Says Real-World Evidence is Here to Stay

Unlike some other buzzwords and shiny tools, the concept of leveraging real-world evidence (RWE) in clinical trials isn’t going anywhere. At least that’s the assessment of big RWE fan and […]

Cancer Drugs Dominate Approval Landscape

In a dramatic upsurge since the 1980s, cancer drugs now account for more than one-fourth of all new drug approvals in the United States since 2010, up from 4% a […]